Enzymatically Amplified Surface Plasmon Resonance Imaging Method Using RNase H and RNA Microarrays for the Ultrasensitive Detection of Nucleic Acids

2004 ◽  
Vol 76 (21) ◽  
pp. 6173-6178 ◽  
Author(s):  
Terry T. Goodrich ◽  
Hye Jin Lee ◽  
Robert M. Corn
2014 ◽  
Vol 53 (26) ◽  
pp. 6037 ◽  
Author(s):  
Pengfei Zhang ◽  
Le Liu ◽  
Yonghong He ◽  
Zhiyuan Shen ◽  
Jun Guo ◽  
...  

ChemBioChem ◽  
2008 ◽  
Vol 9 (13) ◽  
pp. 2067-2070 ◽  
Author(s):  
Roberta D'Agata ◽  
Roberto Corradini ◽  
Giuseppe Grasso ◽  
Rosangela Marchelli ◽  
Giuseppe Spoto

RSC Advances ◽  
2016 ◽  
Vol 6 (26) ◽  
pp. 21900-21906 ◽  
Author(s):  
Xiao Wang ◽  
Jiying Xu ◽  
Chanjuan Liu ◽  
Yi Chen

A surface plasmon resonance imaging method to differentiate the interaction between the protein human high mobility group box 1 or human nuclear protein positive cofactor 4 (PC4) and DNAs has been developed.


2010 ◽  
Vol 25 (9) ◽  
pp. 2095-2100 ◽  
Author(s):  
Roberta D’Agata ◽  
Roberto Corradini ◽  
Cristina Ferretti ◽  
Laura Zanoli ◽  
Marcello Gatti ◽  
...  

2020 ◽  
Vol 8 (39) ◽  
pp. 13563-13573
Author(s):  
Xueyi Luo ◽  
Shijie Deng ◽  
Peng Wang

A surface plasmon resonance (SPR) imaging method for monitoring the electric double-layer (EDL) change dynamics in real-time and map the lateral EDL distribution on heterogeneous electrode/electrolyte interface.


BioTechniques ◽  
2021 ◽  
Author(s):  
Michal Lesnak ◽  
Dominik Jursa ◽  
Marek Miskay ◽  
Helena Riedlova ◽  
Karla Barcova ◽  
...  

Surface plasmon resonance imaging biosensors have a number of advantages that make them superior to other analytical methods. These include the possibility of label-free detection, speed and high sensitivity to low protein concentrations. The aim of this study was to create and analyze biochips, with the help of which it is possible to test cystatin C in patient urine samples and compare the results with the one-time traditional ELISA method. The main advantage of the surface plasmon resonance imaging method is the possibility of repeated measurements over a long period of time in accordance with clinical practice. The surface of the biochip was spotted with anticystatin C and a negative control of mouse IgG at a ratio of 1:1. The aforementioned biochip was first verified using standard tests and then with patient samples, which clearly confirmed the required sensitivity even for very low concentrations of cystatin C.


Sign in / Sign up

Export Citation Format

Share Document